(Reuters) – Modern Inc. said Tuesday it had received a report from the California Department of Health that several people at a San Diego center were being treated for possible allergic reactions to the COVID-19 vaccine from a particular batch .
The company’s comments come after California’s top epidemiologist issued a statement on Sunday recommending suppliers put the vaccine in lot no. 41L20A due to possible allergic reactions being investigated.
“A higher-than-usual number of possible allergic reactions were reported with a specific batch of Modern vaccine administered at a community vaccination clinic. Less than ten people required medical attention within 24 hours,” said the epidemiologist in a statement here. .
The vaccine manufacturer said it was unaware of comparable cases of adverse events from other vaccination centers that could have administered vaccines from the same batch or from other batches of its vaccine.
A total of 307,300 doses in the batch remain stored, Moderna said, out of a total of 1,272,200 doses that were produced in the batch.
Modern said she was working closely with U.S. health regulators to understand the cases and whether it was justified to stop using the lot.
Nearly one million doses of the batch have already been distributed to about 1,700 vaccination sites in 37 states, Moderna said. (bit.ly/39MPtlF)
Reports from Manojna Maddipatla to Bengaluru; Edited by Vinay Dwivedi and Shinjini Ganguli